Pricing Log in Create free account

Revelation Biosciences, Inc. (REVB) vs Silo Pharma, Inc. (SILO)

Revelation Biosciences, Inc. and Silo Pharma, Inc. are both Biotechnology companies. Revelation Biosciences, Inc. and Silo Pharma, Inc. are of similar size ($2.1M and $2.0M). Across the 10 metrics below, Revelation Biosciences, Inc. leads on 5 and Silo Pharma, Inc. on 5.

Valuation

Metric REVB SILO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 20.28 9.40
P/B 0.20 0.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.84 0.86 0.66
EV/Sales n/m (52.27) 9.02
Earnings yield (2,328.22%) (401.69%) (32.88%)
Free cash flow yield (466.23%) (268.42%) (23.13%)

Profitability

Metric REVB SILO Biotechnology median
Gross margin 0.00% 11.81% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (276.43%) (91.23%) (51.96%)
Return on assets (214.63%) (70.96%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric REVB SILO Biotechnology median
Revenue growth (TTM) — 0.00% 6.76%
EPS growth (last fiscal year) 97.72% 57.98% 29.88%
Revenue growth, 5-year CAGR — 12.17% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric REVB SILO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.21 5.36 4.97
Net debt to EBITDA 1.18 1.61 1.01

Dividend

Metric REVB SILO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric REVB SILO Biotechnology median
Market cap 2.02m 2.05m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack